IRIS
GANDAGLIA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.692
NA - Nord America 1.445
AS - Asia 898
SA - Sud America 21
AF - Africa 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.423
SE - Svezia 1.010
IT - Italia 915
SG - Singapore 516
RU - Federazione Russa 370
CN - Cina 222
FI - Finlandia 101
JP - Giappone 72
IE - Irlanda 68
DE - Germania 64
NL - Olanda 36
TR - Turchia 34
FR - Francia 31
GB - Regno Unito 27
IN - India 24
BR - Brasile 14
CA - Canada 14
ES - Italia 8
PL - Polonia 8
CZ - Repubblica Ceca 7
PT - Portogallo 7
BE - Belgio 6
IR - Iran 6
MX - Messico 6
NO - Norvegia 6
LT - Lituania 5
AT - Austria 4
HK - Hong Kong 4
SA - Arabia Saudita 4
AR - Argentina 3
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
ID - Indonesia 3
MA - Marocco 3
VN - Vietnam 3
EU - Europa 2
HU - Ungheria 2
JO - Giordania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
BJ - Benin 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
KZ - Kazakistan 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.071
Salva come PNG Salva come JPEG
Città #
Lawrence 412
Princeton 408
Singapore 301
Milan 202
Moscow 179
New York 116
Helsinki 97
Shanghai 97
Ashburn 95
Dublin 68
Rome 64
Boardman 44
Turin 29
Florence 22
Naples 17
Pune 17
Los Angeles 16
Borås 14
Genoa 14
Guangzhou 14
Palermo 12
Azzano San Paolo 11
Bologna 11
Paris 11
Bari 10
Seattle 10
St Petersburg 10
Washington 10
Dallas 8
Ankara 7
Bursa 7
Padova 7
Tokyo 7
Hayamiya 6
Montepulciano 6
Parma 6
Beijing 5
Boydton 5
Chicago 5
Falconara Marittima 5
Istanbul 5
Lamezia Terme 5
Lisbon 5
Pavia 5
Santa Clara 5
Treviso 5
Vaprio d'Adda 5
Arcore 4
Brescia 4
Modena 4
Munich 4
Oslo 4
Pisa 4
Prague 4
Rockville 4
Sesto San Giovanni 4
Stockholm 4
Vienna 4
Wuxi 4
Xi'an 4
's-Hertogenbosch 3
Aci Sant'antonio 3
Agrigento 3
Alcamo 3
Andria 3
Antakya 3
Bergamo 3
Bolzano 3
Boston 3
Brooklyn 3
Brussels 3
Buenos Aires 3
Casablanca 3
Catania 3
Cefalù 3
Corridonia 3
Council Bluffs 3
Gatchina 3
Gohongi 3
Hanover 3
Ilkley 3
Jeddah 3
Kaunas 3
Lappeenranta 3
London 3
Mexico City 3
Morciano di Romagna 3
Osaka 3
Paderborn 3
Redwood City 3
Sassari 3
Shibuya 3
Sofia 3
São Paulo 3
Trieste 3
Venezia 3
Amman 2
Ancona 2
Athens 2
Atlanta 2
Totale 2.588
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 915
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 40
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 40
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 39
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 33
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 32
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 31
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 30
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 29
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 28
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent 28
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 28
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 25
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 25
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 24
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 24
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 24
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 24
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 24
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 23
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 22
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 22
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 22
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer 22
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 21
Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy 21
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 21
Reply by Authors 21
Improving the stratification of intermediate risk prostate cancer 21
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 21
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 21
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 20
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 20
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 20
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 20
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 20
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 20
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 19
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 19
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 19
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 19
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis 19
IMPATTO DELLA CLIMACTURIA SULLA FUNZIONE ORGASMICA IN PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE RETROPUBICA NERVE SPARING BILATERALE 19
Introducing PIONEER: a project to harness big data in prostate cancer research 19
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 19
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 19
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 19
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 18
Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study). 18
A NOVEL TOOL FOR THE PREDICTION OF URINARY INCONTINENCE AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 18
A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis 18
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 18
A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cancer 18
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 18
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer 18
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 18
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 18
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH) 17
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 17
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 17
A novel tool for the prediction of urinary incontinence after bilateral nerve-sparing radical prostatectomy 17
A systematic review of the association between erectile dysfunction and cardiovascular disease 17
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 17
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons 17
"Trifecta' outcomes of robot-assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis 17
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 17
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 17
The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer 17
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 17
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 16
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy 16
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 16
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 16
Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51 16
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 15
Sentinel node biopsy for prostate cancer: a useless surgical exercise? 15
A detailed analysis of the association between postoperative phosphodiesterase type 5 inhibitor use and the risk of biochemical recurrence after radical prostatectomy 15
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer 15
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy 15
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? 15
Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.012: Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion? 15
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 15
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 14
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis 14
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 14
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research 14
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 14
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 14
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer 14
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 14
European guidelines update on PSMA PET/CT for prostate cancer staging-snap back to reality 13
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Risk of myocardial infarction in patients receiving testosterone therapy: still a matter of debate 13
Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine 13
The role of prostatic inflammation in the development and progression of benign and malignant diseases 13
Cytotoxic Chemotherapy and Targeted Agents 13
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 13
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 13
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 13
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy? 13
Totale 2.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 11 0 0 0 2 2 0 0
2020/2021117 0 0 59 0 0 45 1 1 5 6 0 0
2021/2022364 0 48 39 116 13 19 31 24 10 14 21 29
2022/20232.140 964 443 116 26 15 230 91 136 59 8 28 24
2023/20241.237 24 48 106 92 89 214 116 126 16 110 122 174
2024/20251.441 829 157 149 140 166 0 0 0 0 0 0 0
Totale 5.468